Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ronald P. Savin"'
Autor:
Ronald P. Savin, Phoebe Rich, Nicholas J. Lowe, Adelaide A Hebert, John J. DiGiovanna, Terry M. Jones, David Rodriguez, Sewon Kang, Jonathan Pak, Elyse S. Rafal, Graeme F. Bryce, Douglas R. Eberhardt, Lawrence F. Eichenfield, David M. Pariser, Stacy Smith, Michael Ondovik, Leena P. Shah, John A. McLane, Alan Menter, Mark Ling, Ko Chin Khoo, Julie Newhouse, Michael Jarratt, Craig B. Langman, Steven Kempers, Dan K. Chalker, Emily Wu, Eduardo Tschen, Sabra Sullivan, Catherine Chin
Publikováno v:
Journal of the American Academy of Dermatology. 51:709-717
Background Adverse changes in bone have been reported for patients undergoing high-dose, long-term (several years) isotretinoin therapy for disorders of cornification. The effect of short-term (4-5 months) therapy at the lower dose recommended for ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59feca6fc45d25a2d18d38aeaf40f86a
https://doi.org/10.1016/j.jaad.2004.04.032
https://doi.org/10.1016/j.jaad.2004.04.032
Autor:
Robert J. Pariser, Joseph J. Hong, John S. Strauss, Daniel Stewart, Terry M. Jones, Irving Katz, Jon M. Hanifin, Douglas Eberhardt, Graeme F. Bryce, Anne W. Lucky, Eduardo Tschen, David J. Baginski, Donald P. Lookingbill, David M. Pariser, Lawrence K. Chang, Steven Kempers, Michael Jarratt, Dan K. Chalker, Harry L. Roth, Nicholas J. Lowe, John Arthur Mclane, James J. Leyden, Ronald P. Savin, Elyse S. Rafal, Lynn A. Drake, Eileen E. Leach
Publikováno v:
Journal of the American Academy of Dermatology. 45:196-207
Background: Isotretinoin is a very effective drug for treating severe recalcitrant nodular acne. A new micronized formulation of isotretinoin has been shown to be clinically equivalent to standard isotretinoin with improved bioavailability and minima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83013d9ef8110b2fa6a965b95a59af0c
https://doi.org/10.1067/mjd.2001.115966
https://doi.org/10.1067/mjd.2001.115966
Autor:
Graeme F. Bryce, John Arthur Mclane, Lynn A. Drake, Douglas Eberhardt, P. Harry L. Roth, Eduardo Tschen, Daniel Stewart, Eileen E. Leach, Dan K. Chalker, James J. Leyden, Lawrence K. Chang, Michael Jarratt, Anne W. Lucky, Irving Katz, Ronald P. Savin, Jon M. Hanifin, Nicholas J. Lowe, Elyse S. Rafal, David M. Pariser, Donald P. Lookingbill, Steven Kempers, Joseph J. Hong, John S. Strauss, David J. Baginski, Terry M. Jones, Robert J. Pariser
Publikováno v:
Journal of the American Academy of Dermatology. 45:187-195
Background: Isotretinoin is very frequently the drug of choice for the management of severe recalcitrant nodular acne. Recently, a new micronized and more bioavailable formulation of isotretinoin has been developed that permits once-daily administrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42bf54353409a710ff1eec9c42b42238
https://doi.org/10.1067/mjd.2001.115965
https://doi.org/10.1067/mjd.2001.115965